Stana, Jan; Fernandez Prendes, Carlota; Kruszyna, Lukasz; Passaloglou, Ioannis Thomas; Ruffino, Maria Antonella; Reyes Valdivia, Andres; Del Castro Madrazo, Jose Antonio; Oikonomou, Kyriakos; Chan, Hon Lai; Makaloski, Vladimir; Tsilimparis, Nikolaos (2021). Multicenter Experience With Large Diameter Balloon-Expandable Stent-Grafts for the Treatment of Infrarenal Penetrating Aortic Ulcers. Journal of endovascular therapy, 28(6), pp. 871-877. Sage 10.1177/15266028211028221
|
Text
15266028211028221.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC). Download (536kB) | Preview |
PURPOSE
To describe the use of large-diameter balloon-expandable stent-grafts (BeGraft aortic stent-graft, Bentley InnoMed GmbH, Hechingen, Germany) in the treatment of infrarenal penetrating aortic ulcer (iPAU).
MATERIALS AND METHODS
Retrospective analysis of patients undergoing endovascular treatment with the BeGraft aortic stent-graft in 8 European centers from January 2017 to October 2020. Demographics, perioperative data, and midterm outcomes were collected. Endpoints of the study were technical feasibility, early mortality, and morbidity.
RESULTS
A total of 40 patients were included. The mean age was 73.9±7.05 years and 63.2% were male. Indications for treatment included size and morphology (65%), presence of symptoms (29.5%), and contained ruptures (5.5%). Urgent treatment was performed in 5% of cases. Technical success was 97.5%. Median operation time was 58 minutes (19-170 minutes), with 27.5% of patients having additional procedures during the main intervention (1 additional repair with a C-TAG (W.L. Gore & Associates, Inc, Flagstaff, AZ, USA) thoracic endoprosthesis, 5 covered endovascular reconstruction of aortic bifurcation procedures, 3 extensions with proximal cuffs, and 2 percutaneous angioplasties of the common iliac arteries). Percutaneous femoral access was used in 72.5%, while groin cut-down was performed in 27.5%. Repair was successful with only 1 stent in 45% of cases, while 37.5% required 2 stents and nearly 17.5% required 3/4 stent-grafts. The 30-day mortality was 0%, with a 2.5% reintervention rate (1 patient required evacuation of an intra-abdominal hematoma). Median follow-up was 13.9 months (2-39 months), during which no vascular-related reinterventions or deaths were reported. In 4 patients, a type II endoleak was observed. No cases of graft migration, thrombosis, or stent-fracture were observed.
CONCLUSIONS
The treatment of iPAU with the BeGraft aortic stent-graft in a selective patient group is feasible with low rate of perioperative morbidity and mortality. Balloon-expandable stent-grafts offer the option to repair iPAUs with a shorter coverage of the aorta using low-profile sheath, that enables treatment in the presence of calcified access vessels and small diameter aortic bifurcations.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Heart Surgery |
UniBE Contributor: |
Chan, Hon Lai, Makaloski, Vladimir |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1545-1550 |
Publisher: |
Sage |
Language: |
English |
Submitter: |
Paul Libera |
Date Deposited: |
13 Jan 2022 09:12 |
Last Modified: |
27 Feb 2024 14:28 |
Publisher DOI: |
10.1177/15266028211028221 |
PubMed ID: |
34190634 |
Uncontrolled Keywords: |
atherosclerosis balloon-expandable stent-grafts endovascular aortic repair off-label penetrating aortic ulcer |
BORIS DOI: |
10.48350/162656 |
URI: |
https://boris.unibe.ch/id/eprint/162656 |